CORRESP Filing
Minerva Neurosciences, Inc.
Date: March 17, 2026 · CIK: 0001598646 · Accession: 0001193125-26-109862
AI Filing Summary & Sentiment
File numbers found in text: 333-294203
Show Raw Text
CORRESP 1 filename1.htm CORRESP March 17, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Lauren S. Hamill Re: Minerva Neurosciences, Inc. Registration Statement on Form S-3 File No. 333-294203 Acceleration Request Requested Date: March 19, 2026 Requested Time: 4:00 PM Eastern Time Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “ Registrant ”) hereby requests that the Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the Registration Statement on Form S-3 (File No.: 333-294203) (the “ Registration Statement ”) to become effective on Thursday, March 19, 2026 at 4:00 p.m. Eastern Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Ryan S. Sansom of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Ryan S. Sansom of Cooley LLP, counsel to the Registrant, at (617) 937-2335. Very truly yours, Minerva Neurosciences, Inc. By: /s/ Remy Luthringer Remy Luthringer Chief Executive Officer cc: Remy Luthringer, Chief Executive Officer, Minerva Neurosciences, Inc. Frederick Ahlholm, Chief Financial Officer, Minerva Neurosciences, Inc. Marc Recht, Cooley LLP Ryan S. Sansom, Cooley LLP